Related Experiment Video

Updated: Aug 17, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Pleiotropic effects of statins in atherosclerosis: role on endothelial function, inflammation and immunomodulation

C Arnaud1, F Mach

  • 1Division of Cardiology, Foundation for Medical Research, Faculty of Medicine, Geneva University Hospital, Switzerland.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|July 13, 2005
PubMed

Insights

Statins, potent cholesterol-lowering drugs, exhibit beneficial effects beyond lipid reduction. These cholesterol-independent actions, mediated by inhibiting 3-hydroxyl-3-methylglutaryl coenzyme A (HMG-CoA) reductase, may modulate atherosclerosis.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Biochemistry

Background:

  • Atherosclerosis and its complications are leading causes of mortality in developed nations.
  • Statins are highly effective in lowering serum cholesterol levels and reducing coronary events.

Purpose of the Study:

  • To review the cholesterol-independent, pleiotropic effects of statins.
  • To explore how statins modulate atherogenesis through non-lipid-related mechanisms.

Main Methods:

  • Review of existing literature on statin mechanisms of action.
  • Analysis of the role of 3-hydroxyl-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibition.
  • Examination of isoprenoid intermediate regulation and its impact on signaling proteins.

Main Results:

  • Statins inhibit HMG-CoA reductase, reducing both cholesterol and isoprenoid production.
  • Isoprenoid intermediates (farnesyl pyrophosphate, geranylgeranyl pyrophosphate) regulate signaling proteins like Ras and Rho.
  • Inhibition of prenylated proteins by statins contributes to their pleiotropic, non-lipid-related effects.

Conclusions:

  • Statins possess beneficial pleiotropic effects that extend beyond cholesterol reduction.
  • These effects, linked to the inhibition of isoprenoid synthesis, may play a significant role in modulating atherogenesis.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Inflammation01:38

Inflammation

Overview
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...